2021-11-16-世界卫生组织-Cervical_cancer_Sweden_2021_country_profile_1页_64kb

Morbidity and Mortality:

• Cervical cancer incidence in Sweden was 10.4 per 100,000 women in 2020, with an age-standardized rate of 13 per 100,000. The cumulative risk from ages 0-74 was not specified in 2020. Deaths rose to 46,800 in 2019, with a mortality-to-incidence ratio of 0.3.
• Population data indicates 5,011,000 women in 2019, and a population-based cancer registry exists (2021).

Primary Prevention:

• HPV vaccination coverage among girls was 82% by 2020, with 80% vaccinated by age 15. The program started in 2010, targeting 10-11-year-olds.
• Risk factors included tobacco use prevalence (18% among women aged 15+, 2020) and HIV incidence (0.9%, 2020).
• Pregnancy data was unrelated and omitted.

Secondary Prevention:

• A national cervical cancer screening program exists (2021), using unspecified primary tests; target ages are 23-64/70 years. Ever screened rate is 100%, and 93% screened in the past 5 years.
• High-performance testing is conducted by 35 and 45 years.

Treatment and Supportive Care:

• National guidelines exist for cervical cancer management (2021). Cancer diagnosis and treatment services include radiotherapy (4 units per 10,000 patients), brachytherapy (49 units), pathology services, and various medical staff.
• Palliative care is available, and opioid consumption data is reported.

WHO Elimination Strategy:

• Sweden has high program coverage for primary prevention (82%) and secondary prevention (90% HPV testing by 35 years). Total female population is 5,011,000, with 46,800 deaths in 2019.